These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness. Gungabissoon U, Hacquoil K, Bains C, Irizarry M, Dukes G, Williamson R, Deane AM, Heyland DK. JPEN J Parenter Enteral Nutr; 2015 May; 39(4):441-8. PubMed ID: 24637246 [Abstract] [Full Text] [Related]
11. Any news from the prokinetic front? Deane AM, Chapman MJ, Abdelhamid YA. Curr Opin Crit Care; 2019 Aug; 25(4):349-355. PubMed ID: 31247631 [Abstract] [Full Text] [Related]
12. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Nguyen NQ, Chapman MJ, Fraser RJ, Bryant LK, Holloway RH. Crit Care Med; 2007 Feb; 35(2):483-9. PubMed ID: 17205032 [Abstract] [Full Text] [Related]
17. Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill. Deane AM, Chapman MJ, Reintam Blaser A, McClave SA, Emmanuel A. Nutr Clin Pract; 2019 Feb; 34(1):23-36. PubMed ID: 30294835 [Abstract] [Full Text] [Related]
18. Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients. Btaiche IF, Chan LN, Pleva M, Kraft MD. Nutr Clin Pract; 2010 Feb; 25(1):32-49. PubMed ID: 20130156 [Abstract] [Full Text] [Related]
19. Treating delayed gastric emptying in critical illness: metoclopramide, erythromycin, and bedside (cortrak) nasointestinal tube placement. Taylor SJ, Manara AR, Brown J. JPEN J Parenter Enteral Nutr; 2010 Feb; 34(3):289-94. PubMed ID: 20467010 [Abstract] [Full Text] [Related]